While these data support a role for rituximab in IIM patients complicated by cardiac inflammation, randomized clinical trials are required to confirm these observations. With the available data in the literature, rituximab should be considered as a viable option to treat refractory cardiac manifestations attributed to the inflammatory myopathies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.